Progetto Laser, lotta alla sepsi in Emilia-Romagna - apicella
Progetto Laser, lotta alla sepsi in Emilia-Romagna - apicella Progetto Laser, lotta alla sepsi in Emilia-Romagna - apicella
Inotropi Strategia di ricerca PubMed Progetto LaSER. Lotta alla sepsi in Emilia-Romagna Allegati (sepsis[text] OR “septic shock”[text]) AND (“Dobutamine/administration and dosage”[MeSH] OR “Dobutamine/adverse effects”[MeSH] OR “Dobutamine/analogs and derivatives”[MeSH] OR “Dobutamine/pharmacology”[MeSH] OR “Dobutamine/poisoning”[MeSH] OR “Dobutamine/therapeutic use”[MeSH] OR “Dobutamine/toxicity”[MeSH]) AND (((“outcome and process assessment (health care)”[TIAB] NOT Medline[SB]) OR “outcome and process assessment (health care)”[MeSH Terms] OR Outcome and Process Assessment[Text Word]) OR (“clinical protocols”[MeSH Terms] OR Clinical Protocols[Text Word]) OR (“comparative study”[MeSH Terms] OR Comparative Study[Text Word]) OR (“practice guideline”[Publication Type] OR “practice guidelines”[MeSH Terms] OR “practice guideline”[Text Word]) OR (“controlled clinical trial”[Publication Type] OR “controlled clinical trials”[MeSH Terms] OR “controlled clinical trials”[Text Word]) OR (“randomized controlled trial”[Publication Type] OR “randomized controlled trials”[MeSH Terms] OR “randomized controlled trials”[Text Word]) OR (“meta-analysis”[Publication Type] OR “meta-analysis”[MeSH Terms] OR “meta-analysis”[Text Word]) OR (“review”[Publication Type] OR “review literature”[MeSH Terms] OR “review”[Text Word]) OR (“endpoint determination”[MeSH Terms] OR Endpoint Determination[Text Word])) AND (“2004/01/01”[PDAT] : “2006/06/01”[PDAT]) AND hasabstract[text] AND “humans”[MeSH Terms] Risultati della ricerca PubMed • Beale R.J., Hollenberg S.M., Vincent J.L., Parrillo J.E. Vasopressor and inotropic support in septic shock: an evidence-based review. Crit Care Med, 32 (11 Suppl): S455-S465, Nov 2004. Review. PMID: 15542956 [PubMed - indexed for MEDLINE] • Holmes C.L. Vasoactive drugs in the intensive care unit. Curr Opin Crit Care, 11 (5): 413-417, Oct 2005. Review. PMID: 16175026 [PubMed - indexed for MEDLINE • Lemaire L.C., de Kruif M.D., Giebelen I.A., Levi M., van der Poll T., Heesen M. Dobutamine does not influence inflammatory pathways during human endotoxemia. Crit Care Med, 34 (5): 1365-1371, May 2006. PMID: 16540959 [PubMed - indexed for MEDLINE] • Morelli A., Rocco M., Conti G., Orecchioni A., De Gaetano A., Coluzzi F., Vernaglione E., Pelaia P., Pietropaoli P. Effects of short-term fenoldopam infusion on gastric mucosal blood flow in septic shock. Anesthesiology, 101 (3): 576-582, Sep 2004. PMID: 15329581 [PubMed - indexed for MEDLINE] • Rhodes A., Bennett E.D. Early goal-directed therapy: an evidence-based review. Crit Care Med, 32 (11 Suppl): S448-S450, Nov 2004. Review. PMID: 15542954 [PubMed - indexed for MEDLINE] Dossier 143 76
Progetto LaSER. Lotta alla sepsi in Emilia-Romagna Allegati • Seri I., Noori S. Diagnosis and treatment of neonatal hypotension outside the transitional period. Early Hum Dev, 81 (5): 405-411, May 2005. Review. PMID: 15882935 [PubMed - indexed for MEDLINE] • Trzeciak S., Dellinger R.P., Abate N.L., Cowan R.M., Stauss M., Kilgannon J.H., Zanotti S., Parrillo J.E. Translating research to clinical practice: a 1-year experience with implementing early goal-directed therapy for septic shock in the emergency department. Chest, 129 (2): 225-232, Feb 2006. PMID: 16478835 [PubMed - indexed for MEDLINE] Dossier 143 77
- Page 27 and 28: Progetto LaSER. Lotta alla sepsi in
- Page 29 and 30: Progetto LaSER. Lotta alla sepsi in
- Page 31 and 32: Progetto LaSER. Lotta alla sepsi in
- Page 33 and 34: Progetto LaSER. Lotta alla sepsi in
- Page 35 and 36: 3.2. Diagnosi Progetto LaSER. Lotta
- Page 37 and 38: Progetto LaSER. Lotta alla sepsi in
- Page 39 and 40: 3.4. Antibioticoterapia Progetto La
- Page 41 and 42: Progetto LaSER. Lotta alla sepsi in
- Page 43 and 44: Progetto LaSER. Lotta alla sepsi in
- Page 45 and 46: Progetto LaSER. Lotta alla sepsi in
- Page 47 and 48: Progetto LaSER. Lotta alla sepsi in
- Page 49 and 50: Progetto LaSER. Lotta alla sepsi in
- Page 51 and 52: Progetto LaSER. Lotta alla sepsi in
- Page 53 and 54: Raccomandazione Progetto LaSER. Lot
- Page 55: Allegati Progetto LaSER. Lotta alla
- Page 58 and 59: Progetto LaSER. Lotta alla sepsi in
- Page 60 and 61: Tabella A.1. Risultati degli studi
- Page 62 and 63: Progetto LaSER. Lotta alla sepsi in
- Page 65 and 66: Allegato B. Glossario Progetto LaSE
- Page 67 and 68: Progetto LaSER. Lotta alla sepsi in
- Page 69 and 70: Progetto LaSER. Lotta alla sepsi in
- Page 71 and 72: Fluidoterapia Strategia di ricerca
- Page 73 and 74: Progetto LaSER. Lotta alla sepsi in
- Page 75 and 76: Progetto LaSER. Lotta alla sepsi in
- Page 77: Progetto LaSER. Lotta alla sepsi in
- Page 81 and 82: Progetto LaSER. Lotta alla sepsi in
- Page 83 and 84: Progetto LaSER. Lotta alla sepsi in
- Page 85 and 86: Progetto LaSER. Lotta alla sepsi in
- Page 87 and 88: Progetto LaSER. Lotta alla sepsi in
- Page 89 and 90: Progetto LaSER. Lotta alla sepsi in
- Page 91 and 92: Progetto LaSER. Lotta alla sepsi in
- Page 93 and 94: Progetto LaSER. Lotta alla sepsi in
- Page 95 and 96: Progetto LaSER. Lotta alla sepsi in
- Page 97 and 98: Progetto LaSER. Lotta alla sepsi in
- Page 99 and 100: Proteina C attivata Strategia di ri
- Page 101: Progetto LaSER. Lotta alla sepsi in
- Page 104 and 105: Progetto LaSER. Lotta alla sepsi in
- Page 106 and 107: Progetto LaSER. Lotta alla sepsi in
- Page 109 and 110: COLLANA DOSSIER a cura dell’Agenz
- Page 111 and 112: 39. Rapporti tecnici della Task For
- Page 113 and 114: 82. Applicazione del DLgs 626/94 in
- Page 115: 125. Il clima organizzativo nelle A
Inotropi<br />
Strategia di ricerca PubMed<br />
<strong>Progetto</strong> LaSER. Lotta <strong>alla</strong> <strong>sepsi</strong> <strong>in</strong> <strong>Emilia</strong>-<strong>Romagna</strong><br />
Allegati<br />
(<strong>sepsi</strong>s[text] OR “septic shock”[text]) AND (“Dobutam<strong>in</strong>e/adm<strong>in</strong>istration and<br />
dosage”[MeSH] OR “Dobutam<strong>in</strong>e/adverse effects”[MeSH] OR “Dobutam<strong>in</strong>e/analogs and<br />
derivatives”[MeSH] OR “Dobutam<strong>in</strong>e/pharmacology”[MeSH] OR<br />
“Dobutam<strong>in</strong>e/poison<strong>in</strong>g”[MeSH] OR “Dobutam<strong>in</strong>e/therapeutic use”[MeSH] OR<br />
“Dobutam<strong>in</strong>e/toxicity”[MeSH]) AND (((“outcome and process assessment (health<br />
care)”[TIAB] NOT Medl<strong>in</strong>e[SB]) OR “outcome and process assessment (health<br />
care)”[MeSH Terms] OR Outcome and Process Assessment[Text Word]) OR (“cl<strong>in</strong>ical<br />
protocols”[MeSH Terms] OR Cl<strong>in</strong>ical Protocols[Text Word]) OR (“comparative<br />
study”[MeSH Terms] OR Comparative Study[Text Word]) OR (“practice<br />
guidel<strong>in</strong>e”[Publication Type] OR “practice guidel<strong>in</strong>es”[MeSH Terms] OR “practice<br />
guidel<strong>in</strong>e”[Text Word]) OR (“controlled cl<strong>in</strong>ical trial”[Publication Type] OR “controlled<br />
cl<strong>in</strong>ical trials”[MeSH Terms] OR “controlled cl<strong>in</strong>ical trials”[Text Word]) OR (“randomized<br />
controlled trial”[Publication Type] OR “randomized controlled trials”[MeSH Terms] OR<br />
“randomized controlled trials”[Text Word]) OR (“meta-analysis”[Publication Type] OR<br />
“meta-analysis”[MeSH Terms] OR “meta-analysis”[Text Word]) OR (“review”[Publication<br />
Type] OR “review literature”[MeSH Terms] OR “review”[Text Word]) OR (“endpo<strong>in</strong>t<br />
determ<strong>in</strong>ation”[MeSH Terms] OR Endpo<strong>in</strong>t Determ<strong>in</strong>ation[Text Word])) AND<br />
(“2004/01/01”[PDAT] : “2006/06/01”[PDAT]) AND hasabstract[text] AND<br />
“humans”[MeSH Terms]<br />
Risultati della ricerca PubMed<br />
• Beale R.J., Hollenberg S.M., V<strong>in</strong>cent J.L., Parrillo J.E. Vasopressor and <strong>in</strong>otropic support<br />
<strong>in</strong> septic shock: an evidence-based review. Crit Care Med, 32 (11 Suppl): S455-S465, Nov<br />
2004. Review. PMID: 15542956 [PubMed - <strong>in</strong>dexed for MEDLINE]<br />
• Holmes C.L. Vasoactive drugs <strong>in</strong> the <strong>in</strong>tensive care unit. Curr Op<strong>in</strong> Crit Care, 11 (5):<br />
413-417, Oct 2005. Review. PMID: 16175026 [PubMed - <strong>in</strong>dexed for MEDLINE<br />
• Lemaire L.C., de Kruif M.D., Giebelen I.A., Levi M., van der Poll T., Heesen M.<br />
Dobutam<strong>in</strong>e does not <strong>in</strong>fluence <strong>in</strong>flammatory pathways dur<strong>in</strong>g human endotoxemia. Crit<br />
Care Med, 34 (5): 1365-1371, May 2006. PMID: 16540959 [PubMed - <strong>in</strong>dexed for<br />
MEDLINE]<br />
• Morelli A., Rocco M., Conti G., Orecchioni A., De Gaetano A., Coluzzi F., Vernaglione E.,<br />
Pelaia P., Pietropaoli P. Effects of short-term fenoldopam <strong>in</strong>fusion on gastric mucosal<br />
blood flow <strong>in</strong> septic shock. Anesthesiology, 101 (3): 576-582, Sep 2004. PMID: 15329581<br />
[PubMed - <strong>in</strong>dexed for MEDLINE]<br />
• Rhodes A., Bennett E.D. Early goal-directed therapy: an evidence-based review. Crit<br />
Care Med, 32 (11 Suppl): S448-S450, Nov 2004. Review. PMID: 15542954 [PubMed -<br />
<strong>in</strong>dexed for MEDLINE]<br />
Dossier 143<br />
76